BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB)

Historical Holders from Q4 2020 to Q4 2025

Type / Class: Equity / Common Stocks, par value $0,0001 per share
Symbol: BCAB on Nasdaq
Shares outstanding: 58,548,563
Price per share: $0.5677
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares as of 30 Sep 2025: 13,349,032
Total reported value: $9,190,012
% of total 13F portfolios: 0%
Share change: +165,424
Value change: +$218,759
Avg buy value change: +0%
Avg sell value change: -0%
Number of holders: 43
Price from insider filings: $0.9040

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
HIGHBRIDGE CAPITAL MANAGEMENT LLC	7.7%	-22%	$1,306,686	-$677,599	4,839,579	-34%	Highbridge Capital Management, LLC	31 Mar 2025
ACORN BIOVENTURES, L.P.	8.3%		$2,127,449		4,835,111		Anders Hove	15 May 2025
SHORT JAY M PHD	6.6%		$1,043,724		3,865,646		Jay M. Short	31 Dec 2024
OPOKA INVESTMENT FUND Co	4.8%	-22%	$1,933,227	-$507,296	2,810,331	-21%	OPOKA INVESTMENT FUND Co	09 Jul 2025
MILLENNIUM MANAGEMENT LLC	1.9%		$295,814		1,095,606		Millennium Management LLC	31 Dec 2024

As of 30 Sep 2025, BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) has 43 institutional shareholders filing 13F forms. They hold 13,349,032 shares. of 58,548,563 outstanding shares (23%) .

Top 25 institutional shareholders own 23% of the company.

Filer	Ownership	Nb Shares	Share Change %	Portfolio %	Holdings Value
ACORN CAPITAL ADVISORS, LLC	8.3%	4,835,111	0%	1.7%	$3,336,227
VANGUARD GROUP INC	3.3%	1,945,795	+9.1%	0%	$1,338,707
TANG CAPITAL MANAGEMENT LLC	2.3%	1,374,076	0%	0.04%	$945,227
ACADIAN ASSET MANAGEMENT LLC	1.6%	930,462	-38%	0%	$638,000
RENAISSANCE TECHNOLOGIES LLC	1.4%	800,631	+6.2%	0%	$550,754
DEUTSCHE BANK AG\	0.9%	525,353	0%	0%	$362,494
GEODE CAPITAL MANAGEMENT, LLC	0.85%	495,211	+0.6%	0%	$340,731
BlackRock, Inc.	0.82%	480,933	0%	0%	$330,834
MILLENNIUM MANAGEMENT LLC	0.58%	341,322		0%	$234,795
CITADEL ADVISORS LLC	0.47%	274,036		0%	$188,509
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.43%	252,583	+238%	0%	$173,752
JANE STREET GROUP, LLC	0.33%	194,377	+1034%	0%	$133,712
STATE STREET CORP	0.26%	151,377	0%	0%	$104,132
NORTHERN TRUST CORP	0.17%	100,828	0%	0%	$69,360
UBS Group AG	0.15%	86,743	+193%	0%	$59,680
PVG ASSET MANAGEMENT CORP	0.11%	67,000	+3.1%	0.17%	$46,089
Sheets Smith Investment Management	0.11%	67,000		0.03%	$46,089
Magnus Financial Group LLC	0.08%	47,232	0%	0%	$32,491
MAI Capital Management	0.08%	45,096	+1.9%	0%	$31,022
HRT FINANCIAL LP	0.07%	43,356	+109%	0%	$29,000
TWO SIGMA INVESTMENTS, LP	0.07%	40,716	-51%	0%	$28,009
SIMPLEX TRADING, LLC	0.06%	36,156	+172%	0%	$24,000
CITIGROUP INC	0.04%	26,132		0%	$17,976
COLUMBIA ADVISORY PARTNERS LLC	0.04%	26,070	0%	0.01%	$17,934
COMMONWEALTH EQUITY SERVICES, LLC	0.04%	25,300	0%	0%	$17,000

Institutional Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (% of par)	Investors
2025 Q4	33,769	$19,171	-$15,460			56.77%	2
2025 Q3	13,349,032	$9,190,012	+$218,759		$46,640	68.79%	43
2025 Q2	13,168,921	$5,214,805	-$178,443	$0	$8,197	39.6%	39
2025 Q1	13,676,589	$4,757,169	-$6,041,809	$416	$7,040	34.68%	40
2024 Q4	24,013,047	$14,192,370	-$3,754,504	$33,683	$18,209	59.12%	66
2024 Q3	17,292,318	$30,359,489	-$6,870,050	$58,960	$880	176%	62
2024 Q2	22,134,924	$30,398,249	-$9,185,046	$10,138	$14,659	137%	78
2024 Q1	24,865,828	$85,548,699	-$4,265,784	$15,824	$482,976	344%	83
2023 Q4	17,859	$43,933				246%	1
2023 Q3	29,405,065	$49,988,862	-$3,977,000	$17,170	$112,540	170%	79
2023 Q2	31,514,831	$94,544,563	-$2,354,415	$16,500	$18,300	300%	84
2023 Q1	32,818,125	$87,616,594	-$35,797,013	$97,552	$99,428	268%	78
2022 Q4	33,849,188	$279,246,047	+$75,601,654	$608,025	$1,217,550	825%	87
2022 Q3	22,962,108	$176,828,348	+$12,369,705	$698,000	$1,502,000	769.99%	65
2022 Q2	23,507,118	$66,946,060	-$8,827,590	$126,000	$102,000	284.98%	70
2022 Q1	25,528,610	$127,714,000	-$39,587,136	$377,000	$556,000	500%	90
2021 Q4	25,749,741	$505,464,807	+$1,201,394	$159,000	$2,091,000	1,962.96%	77
2021 Q3	25,335,459	$745,709,968	+$120,246,145			2,943.99%	81
2021 Q2	21,154,721	$896,537,925	+$89,235,042			4,238.01%	74
2021 Q1	19,002,884	$964,589,936	+$187,867,224			5,084.01%	62
2020 Q4	15,664,281	$530,219,000	+$530,209,257			3,400.97%	53